DrugCombination product
Selatogrel clinical trials
Also written ACT-246475.
- studies test it
- 11
- open now
- 2
- in phase 3
- 1
- first study started
- 2011
Keep track of what changes. Save the selatogrel studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
11 studies that test it; most in 2018 (4)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 2
- Phase 3
- 1
Who runs them
Industry 11 · Other 0
Viatris Innovation GmbH (10) · Idorsia Pharmaceuticals Ltd. (1)
Often tested with
Tested in the same studies.
Rifampin (1) · Clopidogrel (1) · Prasugrel (1) · Ticagrelor (1) · ACT-281959 (1)
Studies
Open first, then newest update. How each study uses selatogrel is read from its arms, and is right about nine times in ten.
Testing it · 11
- Selatogrel Outcome Study in Suspected Acute Myocardial InfarctionEnrolling by invitationPhase 3Viatris Innovation GmbHNCT04957719Written as Selatogrel
- A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Chinese Adults With Chronic Coronary SyndromeRecruitingPhase 1Viatris Innovation GmbHNCT07615868Written as Selatogrel
- A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery DiseaseCompletedPhase 2Viatris Innovation GmbHNCT03384966Written as Selatogrel
- A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart AttackCompletedPhase 2Viatris Innovation GmbHNCT03487445Written as Selatogrel 8 mg
- A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy ParticipantsCompletedPhase 1Viatris Innovation GmbHNCT07133191Written as Selatogrel
- The Effect of Reduced Liver Function on Selatogrel PharmacokineticsCompletedPhase 1Viatris Innovation GmbHNCT04406896Written as Selatogrel
- A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy SubjectsCompletedPhase 1Viatris Innovation GmbHNCT04557280Written as Selatogrel
- A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy SubjectsCompletedPhase 1Viatris Innovation GmbHNCT03814200Written as ACT-246475
- A Study to Evaluate ACT-246475 Fate in Healthy Male SubjectsCompletedPhase 1Viatris Innovation GmbHNCT03593278Written as ACT-246475
- A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy SubjectsCompletedPhase 1Viatris Innovation GmbHNCT03430661Written as ACT-246475
- Single-ascending Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-281959 / ACT-246475 in Healthy Male SubjectsCompletedPhase 1Idorsia Pharmaceuticals Ltd.NCT01954615Written as ACT-246475 (Group G dose to be defined)
Codes
What other systems call selatogrel · ClinicalTrials.gg INT000311
- MeSH (NLM) C000601315selatogrelConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 6DPK7O4PR7SELATOGRELConfirmed FDA, NLM, Wikidata
- Wikidata Q76754380selatogrelConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166930SelatogrelOne source FDA
- DrugBank DB15163One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000601315 | selatogrel | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 6DPK7O4PR7 | SELATOGREL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q76754380 | selatogrel | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166930 | Selatogrel | One source FDA |
| DrugBank | DB15163 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.